The increased expression of DNMT1 and DNMT3b was, at least in part, a result of transcription up-regulation of these two genes, as the mRNA levels were correspondingly increased in these two drug resistant breast cancer cell lines (Figure 1C). Here, DNMT3B is linked to breast carcinoma.